251 related articles for article (PubMed ID: 30842500)
1. Rare Pathogenic Variants Predispose to Hepatocellular Carcinoma in Nonalcoholic Fatty Liver Disease.
Pelusi S; Baselli G; Pietrelli A; Dongiovanni P; Donati B; McCain MV; Meroni M; Fracanzani AL; Romagnoli R; Petta S; Grieco A; Miele L; Soardo G; Bugianesi E; Fargion S; Aghemo A; D'Ambrosio R; Xing C; Romeo S; De Francesco R; Reeves HL; Valenti LVC
Sci Rep; 2019 Mar; 9(1):3682. PubMed ID: 30842500
[TBL] [Abstract][Full Text] [Related]
2. Carriage of the PNPLA3 rs738409 C >G polymorphism confers an increased risk of non-alcoholic fatty liver disease associated hepatocellular carcinoma.
Liu YL; Patman GL; Leathart JB; Piguet AC; Burt AD; Dufour JF; Day CP; Daly AK; Reeves HL; Anstee QM
J Hepatol; 2014 Jul; 61(1):75-81. PubMed ID: 24607626
[TBL] [Abstract][Full Text] [Related]
3. Telomerase reverse transcriptase germline mutations and hepatocellular carcinoma in patients with nonalcoholic fatty liver disease.
Donati B; Pietrelli A; Pingitore P; Dongiovanni P; Caddeo A; Walker L; Baselli G; Pelusi S; Rosso C; Vanni E; Daly A; Mancina RM; Grieco A; Miele L; Grimaudo S; Craxi A; Petta S; De Luca L; Maier S; Soardo G; Bugianesi E; Colli F; Romagnoli R; Anstee QM; Reeves HL; Fracanzani AL; Fargion S; Romeo S; Valenti L
Cancer Med; 2017 Aug; 6(8):1930-1940. PubMed ID: 28677271
[TBL] [Abstract][Full Text] [Related]
4. Hepatocellular carcinoma in nonalcoholic fatty liver: role of environmental and genetic factors.
Dongiovanni P; Romeo S; Valenti L
World J Gastroenterol; 2014 Sep; 20(36):12945-55. PubMed ID: 25278690
[TBL] [Abstract][Full Text] [Related]
5. MBOAT7 rs641738 variant and hepatocellular carcinoma in non-cirrhotic individuals.
Donati B; Dongiovanni P; Romeo S; Meroni M; McCain M; Miele L; Petta S; Maier S; Rosso C; De Luca L; Vanni E; Grimaudo S; Romagnoli R; Colli F; Ferri F; Mancina RM; Iruzubieta P; Craxi A; Fracanzani AL; Grieco A; Corradini SG; Aghemo A; Colombo M; Soardo G; Bugianesi E; Reeves H; Anstee QM; Fargion S; Valenti L
Sci Rep; 2017 Jul; 7(1):4492. PubMed ID: 28674415
[TBL] [Abstract][Full Text] [Related]
6. Nonalcoholic fatty liver disease and hepatocellular carcinoma.
Zoller H; Tilg H
Metabolism; 2016 Aug; 65(8):1151-60. PubMed ID: 26907206
[TBL] [Abstract][Full Text] [Related]
7. The characteristics and risk factors of hepatocellular carcinoma in nonalcoholic fatty liver disease without cirrhosis.
Tobari M; Hashimoto E; Taniai M; Kodama K; Kogiso T; Tokushige K; Yamamoto M; Takayoshi N; Satoshi K; Tatsuo A
J Gastroenterol Hepatol; 2020 May; 35(5):862-869. PubMed ID: 31597206
[TBL] [Abstract][Full Text] [Related]
8. Molecular profiling of nonalcoholic fatty liver disease-associated hepatocellular carcinoma using SB transposon mutagenesis.
Kodama T; Yi J; Newberg JY; Tien JC; Wu H; Finegold MJ; Kodama M; Wei Z; Tamura T; Takehara T; Johnson RL; Jenkins NA; Copeland NG
Proc Natl Acad Sci U S A; 2018 Oct; 115(44):E10417-E10426. PubMed ID: 30327349
[TBL] [Abstract][Full Text] [Related]
9. Identification of genes in hepatocellular carcinoma induced by non-alcoholic fatty liver disease.
Cai C; Song X; Yu C
Cancer Biomark; 2020; 29(1):69-78. PubMed ID: 32623384
[TBL] [Abstract][Full Text] [Related]
10. Impact of circulating miR-122 for histological features and hepatocellular carcinoma of nonalcoholic fatty liver disease in Japan.
Akuta N; Kawamura Y; Suzuki F; Saitoh S; Arase Y; Kunimoto H; Sorin Y; Fujiyama S; Sezaki H; Hosaka T; Kobayashi M; Suzuki Y; Kobayashi M; Ikeda K; Kumada H
Hepatol Int; 2016 Jul; 10(4):647-56. PubMed ID: 27074850
[TBL] [Abstract][Full Text] [Related]
11. TERT promoter mutations and chromosome 8p loss are characteristic of nonalcoholic fatty liver disease-related hepatocellular carcinoma.
Ki Kim S; Ueda Y; Hatano E; Kakiuchi N; Takeda H; Goto T; Shimizu T; Yoshida K; Ikura Y; Shiraishi Y; Chiba K; Tanaka H; Miyano S; Uemoto S; Chiba T; Ogawa S; Marusawa H
Int J Cancer; 2016 Dec; 139(11):2512-8. PubMed ID: 27511114
[TBL] [Abstract][Full Text] [Related]
12. PNPLA3 I148M polymorphism, clinical presentation, and survival in patients with hepatocellular carcinoma.
Valenti L; Motta BM; Soardo G; Iavarone M; Donati B; Sangiovanni A; Carnelutti A; Dongiovanni P; Rametta R; Bertelli C; Facchetti F; Colombo M; Fargion S; Fracanzani AL
PLoS One; 2013; 8(10):e75982. PubMed ID: 24155878
[TBL] [Abstract][Full Text] [Related]
13. Clinical features of hepatocellular carcinoma in nonalcoholic fatty liver disease patients without advanced fibrosis.
Kodama K; Kawaguchi T; Hyogo H; Nakajima T; Ono M; Seike M; Takahashi H; Nozaki Y; Kawanaka M; Tanaka S; Imajo K; Sumida Y; Kamada Y; Fujii H; Seko Y; Takehara T; Itoh Y; Nakajima A; Masaki N; Torimura T; Saibara T; Karino Y; Chayama K; Tokushige K
J Gastroenterol Hepatol; 2019 Sep; 34(9):1626-1632. PubMed ID: 30668889
[TBL] [Abstract][Full Text] [Related]
14. Unique features associated with hepatic oxidative DNA damage and DNA methylation in non-alcoholic fatty liver disease.
Nishida N; Yada N; Hagiwara S; Sakurai T; Kitano M; Kudo M
J Gastroenterol Hepatol; 2016 Sep; 31(9):1646-53. PubMed ID: 26875698
[TBL] [Abstract][Full Text] [Related]
15. Bioinformatics analysis reveals novel core genes associated with nonalcoholic fatty liver disease and nonalcoholic steatohepatitis.
Feng G; Li XP; Niu CY; Liu ML; Yan QQ; Fan LP; Li Y; Zhang KL; Gao J; Qian MR; He N; Mi M
Gene; 2020 Jun; 742():144549. PubMed ID: 32184169
[TBL] [Abstract][Full Text] [Related]
16. Hepatocellular carcinoma and non-alcoholic steatohepatitis: The state of play.
Charrez B; Qiao L; Hebbard L
World J Gastroenterol; 2016 Feb; 22(8):2494-502. PubMed ID: 26937137
[TBL] [Abstract][Full Text] [Related]
17. Elevated levels of circulating ITIH4 are associated with hepatocellular carcinoma with nonalcoholic fatty liver disease: from pig model to human study.
Nakamura N; Hatano E; Iguchi K; Sato M; Kawaguchi H; Ohtsu I; Sakurai T; Aizawa N; Iijima H; Nishiguchi S; Tomono T; Okuda Y; Wada S; Seo S; Taura K; Uemoto S; Ikegawa M
BMC Cancer; 2019 Jun; 19(1):621. PubMed ID: 31238892
[TBL] [Abstract][Full Text] [Related]
18. Rare ATG7 genetic variants predispose patients to severe fatty liver disease.
Baselli GA; Jamialahmadi O; Pelusi S; Ciociola E; Malvestiti F; Saracino M; Santoro L; Cherubini A; Dongiovanni P; Maggioni M; Bianco C; Tavaglione F; Cespiati A; Mancina RM; D'Ambrosio R; Vaira V; Petta S; Miele L; Vespasiani-Gentilucci U; Federico A; Pihlajamaki J; Bugianesi E; Fracanzani AL; Reeves HL; Soardo G; Prati D; Romeo S; Valenti LV;
J Hepatol; 2022 Sep; 77(3):596-606. PubMed ID: 35405176
[TBL] [Abstract][Full Text] [Related]
19. Diabetic Retinopathy as a Risk Factor Associated with the Development of Hepatocellular Carcinoma in Nonalcoholic Fatty Liver Disease.
Azuma S; Asahina Y; Kakinuma S; Azuma K; Miyoshi M; Inoue E; Tsunoda T; Sato A; Kaneko S; Nagata H; Kawai-Kitahata F; Murakawa M; Nitta S; Itsui Y; Tomita M; Nakagawa M; Watanabe M
Dig Dis; 2019; 37(3):247-254. PubMed ID: 30625487
[TBL] [Abstract][Full Text] [Related]
20. Clinical Patterns and Outcome of Hepatocellular Carcinoma in Patients with Nonalcoholic Fatty Liver Disease.
Ahn SY; Kim SB; Song IH
Can J Gastroenterol Hepatol; 2020; 2020():4873875. PubMed ID: 32566546
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]